Valuation: Terumo Corporation

Market Cap 3,54800Cr 2.24TCr 2TCr 1.85TCr 1.68TCr 3.16TCr 2,11800Cr 3.19TCr 22TCr 8.71TCr 1,11300Cr 8.42TCr 8.24TCr P/E 2027 *
29.2x
P/E 2028 * 18.6x
Enterprise Value 3,61300Cr 2.29TCr 2.04TCr 1.89TCr 1.71TCr 3.22TCr 2,15700Cr 3.25TCr 23TCr 8.87TCr 1,13400Cr 8.57TCr 8.4TCr EV / Sales 2027 *
2.88x
EV / Sales 2028 * 2.67x
Free-Float
97.34%
Yield 2027 *
1.43%
Yield 2028 * 1.64%

Last Transcript: Terumo Corporation

1 day+1.02%
1 week+5.52%
Current month+5.77%
1 month+6.81%
3 months+10.48%
6 months+15.01%
Current year+7.03%
1 week 2,250
Extreme 2250
2,465
1 month 2,215.5
Extreme 2215.5
2,465
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,900
Extreme 1900
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%+5.52%-6.61%+25.69% 2.24TCr
-1.89%-2.39%-21.19%+3.85% 17TCr
-2.23%+5.67%-21.63%+12.01% 11TCr
-1.69%-1.27%-2.92%+27.96% 11TCr
+0.12%+17.05%-44.11%+5.17% 8.96TCr
-0.83%+1.27%+3.53%+80.36% 6.5TCr
-0.47%+5.71%+14.57%+81.93% 5.61TCr
+0.28%+2.89%+2.81%-24.86% 5.29TCr
-0.80%+4.63%-13.13%+29.62% 4.36TCr
+0.04%+1.49%-8.17%-13.73% 3.28TCr
Average -0.64%+4.67%-9.69%+22.80% 7.64TCr
Weighted average by Cap. -1.10%+3.67%-13.39%+20.42%

Financials

2027 *2028 *
Net sales 1,25500Cr 793.97Cr 707.51Cr 655.04Cr 592.79Cr 1.12TCr 75TCr 1.13TCr 7.85TCr 3.08TCr 39TCr 2.98TCr 2.92TCr 1,32400Cr 837.85Cr 746.61Cr 691.24Cr 625.55Cr 1.18TCr 79TCr 1.19TCr 8.29TCr 3.25TCr 42TCr 3.14TCr 3.08TCr
Net income 12TCr 77Cr 68Cr 63Cr 57Cr 108.09Cr 7.25TCr 109.37Cr 760.08Cr 298.24Cr 3.81TCr 288.25Cr 282.25Cr 19TCr 120.6Cr 107.46Cr 99Cr 90Cr 169.63Cr 11TCr 171.64Cr 1.19TCr 468.07Cr 5.98TCr 452.39Cr 442.97Cr
Net Debt 6.51TCr 41Cr 37Cr 34Cr 31Cr 58Cr 3.88TCr 59Cr 407.16Cr 159.76Cr 2.04TCr 154.41Cr 151.2Cr -1.68TCr -11Cr -9.49Cr -8.79Cr -7.95Cr -15Cr -1.01TCr -15Cr -105.35Cr -41Cr -528.3Cr -40Cr -39Cr
Projected Income Statement - Annual - Terumo Corporation
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
22/26/22 JP¥2,429.50 +1.02% 56,97,700
21/26/21 JP¥2,405.00 -0.06% 62,82,300
20/26/20 JP¥2,406.50 +2.84% 59,45,300
19/26/19 JP¥2,340.00 +0.13% 53,77,900
16/26/16 JP¥2,337.00 +1.50% 60,24,600
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Terumo Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,405.00JPY
Average target price
3,012.31JPY
Spread / Average Target
+25.25%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Terumo Corporation
  1. Stock Market
  2. Stocks
  3. 4543 Stock